Toll Free: 1-888-928-9744

Live Cell Imaging Market Outlook 2022

Published: May, 2018 | Pages: 110 | Publisher: RNCOS
Industry: Healthcare | Report Format: Electronic (PDF)

The global live cell imaging market is projected to grow at a significant CAGR during the forecast period. Live cell imaging is gaining a wider audience since it is used as a popular tool for biological mechanisms and contributes significantly to the functions of multiple cellular processes. Therefore, it is necessary for user to perform a live cell imaging near under biological conditions to prevent any ineffective cellular behaviour. 

The drivers for live cell imaging market include rise in funding for R&D and strategic collaborations for drug delivery & research. Subsequently, the market growth is also backed by rise in prevalence of chronic disorders and demand for diagnostic facilities. Increase in R&D and cell development activities enable cell imaging for further reference. Use of imaging for cell biologists helps them understand the fundamental nature of cell structure and function. 

Application segment for live cell imaging market includes developmental biology, stem cell & drug discovery, drug genetics, immunology, microbiology and neurobiology. Technological segment for live cell imaging 

Geographical segmentation for live cell imaging market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America followed by Europe dominates the live cell imaging market owing to significant investments and funding for research & development. Inception of private research institutes and advances in medical technology is likely to propel the market growth during the forecast period. 

Asia-Pacific regions are likely to grow at a higher rate due to availability of patient pool and prevalence of chronic diseases. Stem cell research and rise in funding for cell and developmental biology is likely to enlarge the market size during the forecast period. The key players in the live cell imaging market include Nikon Corporation, Carl Zeiss, GE Healthcare, Olympus Corporation, Thermo Fisher Scientific Inc, Sigma-Aldrich Corporation, Molecular Devices LLC and Perkin Elmer Inc.

Live Cell Imaging is defined as the study of living cells using high content screening or analysis systems and imaging systems such as microscopes, cell analyzers, etc. These technologies are used in number of investigations in order to provide critical insights into the fundamental nature of tissue and cellular function. 

The new report introduced by RNCOS entitled "Live Cell Imaging Market Outlook 2022", includes a comprehensive analysis of the current and future outlooks of the Live Cell Imaging industry. The live cell imaging market is expected to reach US$ 7 Billion by 2022.

The report presents an in-depth analysis of several techniques used in imaging of live cells; as well as the segmentation of market by products, applications, technology and geography. Based on product types, the market has been segmented into equipments, consumables and softwares. Equipment market is expected to account for the largest share in 2016. According to technologies used in live cell imaging, the market has been divided into FRET, FISH, and other major techniques. 

Similarly, geographical regions include North America, Europe, Asia Pacific and Rest of the World. North America is the largest market for live cell imaging due to high number of cell biology researches conducted in the region. As per RNCOS' analysis, live cell imaging is widely entering into a number of fields such as cell biology, developmental biology, drug discovery, stem cell biology, neurobiology and electrophysiology. It is emerging as a powerful tool for providing critical insights into cell function, including dynamic processes in living cells with nano-scale resolution in real time. Recent advances in microscopy techniques such as fluorescence light microscopy, including super resolution, photo activation, etc. and confocal microscopy are moving live cell imaging for a number of applications.

The last section of the report discusses about the prominent players in global live cell imaging market. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development and strength weakness analysis of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global live cell imaging market.
 Table of Contents

1. Analyst View

2. Research Methodology

3. Live Cell Imaging - An Introduction

4. Global Live Cell Imaging Market Overview

5. Market Dynamics
     5.1 Drivers
            5.1.1 Rising Incidences of Chronic Diseases
            5.1.2 Surging Demand for High-Content Screening Techniques
            5.1.3 Increasing Funding Support by Public and Private Sector
            5.1.4 Availability of Long-term Live Cell Imaging Platform
            5.1.5 Live Cell Imaging Instruments Accelerating Drug Discovery
     5.2 Challenges
            5.2.1 Maintaining Live Cells on Microscope Stage
            5.2.2 Mimicking the In Vivo Microenvironment
            5.2.3 Lack of Awareness
     5.3 Opportunities
            5.3.1 Adoption of High Content Screening Systems for Primary Screening
            5.3.2 Application of In Vivo Live Cell Imaging Techniques

6. Global Live Cell Imaging Market By Product
     6.1 Equipment
     6.2 Consumables
     6.3 Software

7. Global Live Cell Imaging Market by Application
     7.1 Cell Biology
     7.2 Developmental Biology
     7.3 Stem Cell Biology
     7.4 Drug Discovery
     7.5 Other Applications

8. Global Live Cell Imaging Market By Technology
     8.1 Fluorescent Resonance Energy Transfer (FRET)
     8.2 High Content Analysis (HCA)
     8.3 Fluorescence In Situ Hybridization (FISH)
     8.4 Other Technologies

9. Global Live Cell Imaging Market By Geography
     9.1 North America
     9.2 Europe
     9.3 Asia Pacific
     9.4 Rest of the World

10. Trends & Developments
       10.1 Fluorescent Probes Enriching Live Cell Imaging
       10.2 Introduction of LiveCyte Kinetic Cytometer for Label-free, Quantitative Phase Imaging
       10.3 Live Cell Imaging Revealing Intracellular Interactions
       10.4 Introduction of Single Plane Illumination Microscopy Advancing Live Cell Imaging

11. Mergers & Other Collaborations

12. Company Profiles
       12.1 Carl Zeiss GmbH
       12.2 Becton Dickenson & Co.
       12.3 Olympus Corporation
       12.4 ThermoFisher Scientific Inc.
       12.5 Merck KGaA
       12.6 Perkin Elmer, Inc.
       12.7 Nikon Instruments Inc.
       12.8 GE Healthcare
       12.9 Lonza
       12.10 Danaher Corporation
List of Tables:

Table 5-1: Global - Cancer Mortality Cases (Million), 2015 & 2020
Table 5-2: Funds Announced for Live Cell Imaging Research (2013-2015)
Table 9-1: North America - Elderly Population (Million), 2015 & 2030
Table 9-2: North America - Cancer Incidences (Million), 2015 & 2025
Table 9-3: Europe - Elderly Population (Million), 2015 & 2030
Table 9-4: Europe - Cancer Incidences (Million), 2015 & 2025
Table 9-5: Asia Pacific - Elderly Population (Million), 2015 & 2030
Table 9-6: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
Table 9-7: Latin America - Elderly Population (Million), 2015 & 2030
Table 9-8: Latin America - Cancer Incidences (Million), 2015 & 2025
Table 9-9: Africa - Elderly Population (Million), 2015 & 2030
Table 9-10: Africa - Cancer Incidences (Million), 2015 & 2025
Table 12-1: Carl Zeiss GmBH - Key Financials (Million US$), FY 2013-FY 2015
Table 12-2: Becton Dickenson & Co. - Key Financials(Million US$), 2013-2015
Table 12-3: Olympus Corporation - Key Financials (Million US$), 2013-2015
Table 12-4: ThermoFisher Scientific Inc.- Key Financials (Million US$), 2013-2015
Table 12-5: Merck KGaA - Key Financials (Million US$), 2013-2015
Table 12-6: Perkin Elmer Inc. - Key Financials (Million US$), 2013-2015
Table 12-7: Nikon Instruments Inc. - Key Financials (Million US$), 2013-2015
Table 12-8: GE Healthcare - Key Financials (Million US$), 2013-2015
Table 12-9: Lonza - Key Financials (Million US$), 2013-2015
Table 12-10: Danaher Corporation - Key Financials (Million US$), 2013-2015 

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $2200
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.